# CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention

> **NCT06283888** · PHASE4 · RECRUITING · sponsor: **Zunyi Medical College** · enrollment: 1200 (estimated)

## Conditions studied

- ACS - Acute Coronary Syndrome
- CYP2C19 Polymorphism

## Interventions

- **DRUG:** CYP2C19 Genotype Guided DAPT
- **DRUG:** Conventional DAPT

## Key facts

- **NCT ID:** NCT06283888
- **Lead sponsor:** Zunyi Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2028-04-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2024-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06283888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06283888, "CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT06283888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*